FOSRENOL  1000 MG CHEWABLE TABLETS Israël - anglais - Ministry of Health

fosrenol 1000 mg chewable tablets

takeda israel ltd - lanthanum as carbonate hydrate - chewable tablets - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

FOSRENOL lanthanum 1000 mg (as lanthanum carbonate hydrate) chewable tablet bottle Australie - anglais - Department of Health (Therapeutic Goods Administration)

fosrenol lanthanum 1000 mg (as lanthanum carbonate hydrate) chewable tablet bottle

takeda pharmaceuticals australia pty ltd - lanthanum carbonate hydrate, quantity: 1908 mg - tablet, chewable - excipient ingredients: dextrates; magnesium stearate; silicon dioxide - treatment of hyperphosphataemia in adults with chronic renal failure on haemodialysis or continuous ambulatory peritoneal dialysis (capd).

FOSRENOL lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle Australie - anglais - Department of Health (Therapeutic Goods Administration)

fosrenol lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle

takeda pharmaceuticals australia pty ltd - lanthanum carbonate hydrate, quantity: 1431 mg - tablet, chewable - excipient ingredients: dextrates; magnesium stearate; silicon dioxide - treatment of hyperphosphataemia in adults with chronic renal failure on haemodialysis or continuous ambulatory peritoneal dialysis (capd).

FOSRENOL lanthanum 500mg (as lanthanum carbonate hydrate) chewable tablet bottle Australie - anglais - Department of Health (Therapeutic Goods Administration)

fosrenol lanthanum 500mg (as lanthanum carbonate hydrate) chewable tablet bottle

takeda pharmaceuticals australia pty ltd - lanthanum carbonate hydrate, quantity: 954 mg - tablet, chewable - excipient ingredients: dextrates; silicon dioxide; magnesium stearate - treatment of hyperphosphataemia in adults with chronic renal failure on haemodialysis or continuous ambulatory peritoneal dialysis (capd).

Halothane Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

halothane

pharmachem australia pty ltd - halothane - unknown - halothane anaesthetic active 0.0 - active constituent

HALOTHANE SOLUTION Canada - anglais - Health Canada

halothane solution

bimeda-mtc animal health inc - halothane - solution - 99.99% - halothane 99.99% - inhalation anesthetics

HALOTHANE LIQ 99.9% LIQUID Canada - anglais - Health Canada

halothane liq 99.9% liquid

halocarbon laboratories, a division of halocarbon products corp - halothane - liquid - 99.9% - halothane 99.9% - inhalation anesthetics

LANTHANUM CARBONATE OD Tablets 250mg "ISEI" (炭酸ランタンOD錠250mg「イセイ」) Japon - anglais - すりの適正使用協議会 RAD-AR Council, Japan

lanthanum carbonate od tablets 250mg "isei" (炭酸ランタンod錠250mg「イセイ」)

koa isei co.,ltd. - lanthanum carbonate hydrate - white to grayish white tablet, diameter: 10.5 mm, thickness: 4.6 mm